Stay updated on Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedEnrollment status updated to No longer looking for participants, affecting recruitment visibility. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study), along with an updated Intervention/Treatment heading and the Revision: v3.6.0 label to reflect the latest update.SummaryDifference0.4%

- Check18 days agoChange DetectedRevision label changed from v3.5.4 to v3.5.5, reflecting a software version update on the page.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.5.4 was applied to the page, replacing the previous v3.5.3; this is a metadata/version update and does not modify the study data or content.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page’s footer/site revision version has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or release update rather than any study-specific information.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This is a metadata/version update and does not alter study data or content.SummaryDifference0.1%

- Check75 days agoChange DetectedNew milestone dates were added and older dates removed in the Study Record Dates section, updating the trial's projected completion timeline.SummaryDifference0.3%

Stay in the know with updates to Nivolumab and Urelumab in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and Urelumab in Bladder Cancer Clinical Trial page.